Search Results

Genetown

First Patients Treated with TISSIUM’s Atraumatic Hernia Repair System

TISSIUM announced the first clinical use of TISSIUM’s Adhesive Hernia Repair System in patients undergoing laparoscopic ventral hernia repair as part of the ALPHA clinical study taking place in Belgium.

September 12, 2023

·

3 min read

Genetown

First Patients Treated with TISSIUM’s Atraumatic Sutureless Nerve Coaptation System

TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue reconstruction, announced today the successful implantations of the first patients with its COAPTIUM Connect Sutureless Nerve Coaptation System as part of its peripheral nerve repair study in Australia.

March 30, 2023

·

3 min read

Genetown

TISSIUM Obtains a Non-Dilutive Financing of €4.2 Million Within the Framework of the “FRANCE 2030" Plan

TISSIUM, a private medtech specializing in the development of programmable biomorphic polymers for tissue reconstruction, announces it has obtained a non-dilutive financing of €4.2 million from Bpifrance as part of the “France 2030" plan to extend its production capacity for “large volume” syringes.

June 15, 2023

·

2 min read

Genetown

TISSIUM Raises €50M in Series D Funding to Finance its Commercial Launch and Platform Extension

TISSIUM announced it has closed a Series D round of financing, raising €50 million from new and existing international investors, including Fonds Stratégique des Transitions, managed by ISALT, Merieux Developpement and returning Cathay Health, Credit Mutuel Innovation and Sofinnova Partners.

May 23, 2023

·

2 min read

Business

TISSIUM Appoints Alex Milstein as Chief Medical Officer

TISSIUM, a privately-owned medical technology company developing a portfolio of biomorphic programmable polymers for tissue reconstruction, announced it has appointed Dr. Alex Milstein as its Chief Medical Officer.

January 17, 2023

·

3 min read

Business

TISSIUM Appoints Sara Toyloy as Independent Board Member

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has appointed Sara Toyloy as its fourth independent member of the Board of Directors.

September 26, 2022

·

3 min read

Business

Tissium Appoints Maria Sainz as Independent Board Member

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has appointed Maria Sainz as an independent member of the Board of Directors.

July 12, 2022

·

3 min read

Business

TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has appointed Ruth Krestin as Vice President of Portfolio Strategy within TISSIUM.

January 10, 2022

·

3 min read

Business

TISSIUM Appoints Romain Attard as Chief Financial Officer

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced Romain Attard has been appointed Chief Financial Officer of TISSIUM.

July 1, 2021

·

3 min read

TISSIUM to Present Study Results at the 76th Annual Meeting of the American Society for Surgery of the Hand

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has announced its research has been selected for presentation within the scientific program at the 76th Annual Meeting of the American Society for Surgery of the Hand.

September 24, 2021

·

3 min read